Home / Research
Each Koi lot ships with a third-party COA tied to a public lot ID printed on the vial. Search by lot ID or compound name to pull the analytical package — purity, mass-spec, counterion content, and endotoxin screen.
Lot lookup
Lot IDs follow the format KOI-YYYY-MMDD-x and are printed directly on the vial.
Showing 1–8 of 32 documents
| Compound | Lot ID | Purity | Tested | Action |
|---|---|---|---|---|
| BPC-157 Acetate | KOI-2026-0418-A | 99.4% | Apr 18, 2026 | View COA → |
| BPC-157 Acetate — Endotoxin | KOI-2026-0418-A | 99.4% | Apr 18, 2026 | View COA → |
| BPC-157 + TB-500 (Wolverine) | KOI-2026-0410-B | 99.1% | Apr 10, 2026 | View COA → |
| BPC-157 + TB-500 (Wolverine) — BPC-157 Endo | KOI-2026-0410-B | 99.1% | Apr 10, 2026 | View COA → |
| BPC-157 + TB-500 (Wolverine) — TB-500 Endo | KOI-2026-0410-B | 99.1% | Apr 10, 2026 | View COA → |
| CJC-1295 no DAC + Ipamorelin | KOI-2026-0405-C | 99.0% | Apr 05, 2026 | View COA → |
| CJC-1295 no DAC + Ipamorelin — CJC Endo | KOI-2026-0405-C | 99.0% | Apr 05, 2026 | View COA → |
| CJC-1295 no DAC + Ipamorelin — Ipamorelin Endo | KOI-2026-0405-C | 99.0% | Apr 05, 2026 | View COA → |
| GHK-Cu | KOI-2026-0409-A | 99.4% | Apr 09, 2026 | View COA → |
| GHK-Cu — Endotoxin | KOI-2026-0409-A | 99.4% | Apr 09, 2026 | View COA → |
| GLOW (BPC-157 + GHK-Cu + TB-500) | KOI-2026-0405-B | 99.2% | Apr 05, 2026 | View COA → |
| GLOW (BPC-157 + GHK-Cu + TB-500) — BPC-157 Endo | KOI-2026-0405-B | 99.2% | Apr 05, 2026 | View COA → |
| GLOW (BPC-157 + GHK-Cu + TB-500) — GHK Endo | KOI-2026-0405-B | 99.2% | Apr 05, 2026 | View COA → |
| GLOW (BPC-157 + GHK-Cu + TB-500) — TB-500 Endo | KOI-2026-0405-B | 99.2% | Apr 05, 2026 | View COA → |
| Ipamorelin | KOI-2026-0413-A | 99.5% | Apr 13, 2026 | View COA → |
| Ipamorelin — Endotoxin | KOI-2026-0413-A | 99.5% | Apr 13, 2026 | View COA → |
| KLOW (BPC-157 + GHK-Cu + KPV + TB-500) | KOI-2026-0406-A | 99.1% | Apr 06, 2026 | View COA → |
| KLOW (BPC-157 + GHK-Cu + KPV + TB-500) — BPC-157 Endo | KOI-2026-0406-A | 99.1% | Apr 06, 2026 | View COA → |
| KLOW (BPC-157 + GHK-Cu + KPV + TB-500) — GHK Endo | KOI-2026-0406-A | 99.1% | Apr 06, 2026 | View COA → |
| KLOW (BPC-157 + GHK-Cu + KPV + TB-500) — TB-500 Endo | KOI-2026-0406-A | 99.1% | Apr 06, 2026 | View COA → |
| NAD+ | KOI-2026-0410-A | 99.8% | Apr 10, 2026 | View COA → |
| NAD+ — Endotoxin | KOI-2026-0410-A | 99.8% | Apr 10, 2026 | View COA → |
| Retatrutide | KOI-2026-0422-B | 99.1% | Apr 22, 2026 | View COA → |
| Retatrutide — Endotoxin | KOI-2026-0422-B | 99.1% | Apr 22, 2026 | View COA → |
| Semaglutide | KOI-2026-0417-C | 99.5% | Apr 17, 2026 | View COA → |
| Semaglutide — Endotoxin | KOI-2026-0417-C | 99.5% | Apr 17, 2026 | View COA → |
| TB-500 | KOI-2026-0415-A | 99.3% | Apr 15, 2026 | View COA → |
| TB-500 — Endotoxin | KOI-2026-0415-A | 99.3% | Apr 15, 2026 | View COA → |
| Tesamorelin | KOI-2026-0419-B | 99.7% | Apr 19, 2026 | View COA → |
| Tesamorelin — Endotoxin | KOI-2026-0419-B | 99.7% | Apr 19, 2026 | View COA → |
| Tirzepatide | KOI-2026-0421-A | 99.2% | Apr 21, 2026 | View COA → |
| Tirzepatide — Endotoxin | KOI-2026-0421-A | 99.2% | Apr 21, 2026 | View COA → |
Double-check the lot ID printed on your vial, or email [email protected] with the batch number.
Testing methods
All testing is performed in-house and re-run by an independent ISO 17025–accredited laboratory. Both result sets are published against the lot ID.
Reverse-phase high-performance liquid chromatography quantifies peptide purity. Lots must measure ≥99% by integrated peak area for release. The chromatogram is published with the COA.
Electrospray-ionization mass spectrometry confirms molecular weight and sequence integrity. Fragmentation patterns flag any synthesis errors or modifications before the material leaves the bench.
ICP-MS detects Pb, As, Cd, Hg below 10 ppm. Bacterial endotoxins are quantified by LAL assay. Counterion content (acetate / TFA) is reported per lot.
No account yet?
Create an Account